Concepedia

Ketan Mathavan

KM

Statistics

Publications

7

Citations

138

H-Index

7

Active since

2017

Affiliations

University of Massachusetts Amherst(Current)

Fate Therapeutics (United States)

Max Delbrück Center

Ketan Mathavan is an author at University of Massachusetts Amherst specializing in cell signaling, medicine, and developmental biology.

Top concepts

Publications per year

2017–2024

7

Publications

7

The ectodomain of cadherin-11 binds to erbB2 and stimulates Akt phosphorylation to promote cranial neural crest cell migration

Ketan Mathavan, Vikram Khedgikar, Vanessa Bartolo et al. · PLoS ONE · 2017 · 28 citations · Full text

, , +16

Endoplasmic reticulum transmembrane protein TMTC3 contributes to O-mannosylation of E-cadherin, cellular adherence, and embryonic gastrulation

Jill B. Graham, Johan C. Sunryd, Ketan Mathavan et al. · Molecular Biology of the Cell · 2019 · 27 citations · Full text

FT555: Off-the-Shelf CAR-NK Cell Therapy Co-Targeting GPRC5D and CD38 for the Treatment of Multiple Myeloma

John Reiser, Szeman Ruby Chan, Ketan Mathavan et al. · Blood · 2022 · 23 citations

<i>Xenopus</i> ADAM19 regulates Wnt signaling and neural crest specification by stabilizing ADAM13

Jiejing Li, Mark Perfetto, Russell Neuner et al. · Development · 2018 · 22 citations · Full text

CXCR4 has a dual role in improving the efficacy of BCMA-redirected CAR-NK cells in multiple myeloma

Michael W. Moles, Henry Erdlei, Lutz Menzel et al. · Frontiers in Immunology · 2024 · 16 citations · Full text

Rows per page

1–5 of 7